Inventor · disambiguated record
Zong Sean Juo
Also filed as: JUO ZONG SEAN
12 granted patents·14 pending applications·11 citations·filing 2015–2025
85Inventor score
Top patents by PatentIndex Score
26 records- 0187US10875929B2Tissue factor pathway inhibitor antibodies and uses thereofPFIZER·Filed 2019·Granted Dec 29, 2020·3 cites·18 claims
- 0287US2025145732A1Tissue factor pathway inhibitor antibodies and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 0385US12157771B2Proteins binding NKG2D, CD16 and CLEC12ADRAGONFLY THERAPEUTICS INC·Filed 2021·Granted Dec 3, 2024·1 cites·21 claims
- 0485US10550200B2Tissue factor pathway inhibitor antibodies and uses thereofPFIZER·Filed 2016·Granted Feb 4, 2020·5 cites·9 claims
- 0584US11634504B2Tissue factor pathway inhibitor antibodies and uses thereofPFIZER·Filed 2020·Granted Apr 25, 2023·1 cites·8 claims
- 0683US12168698B2Tissue factor pathway inhibitor antibodies and uses thereofPFIZER·Filed 2023·Granted Dec 17, 2024·0 cites·11 claims
- 0773US2024270861A1Proteins binding nkg2d, cd16 and baff-rDRAGONFLY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0873US2024360223A1Proteins binding nkg2d, cd16 and baff-rDRAGONFLY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0969US11008373B2Designer osteogenic proteinsWYETH LLC·Filed 2018·Granted May 18, 2021·0 cites·8 claims
- 1067US9688735B2Designer osteogenic proteinsBERASI STEPHEN·Filed 2015·Granted Jun 27, 2017·1 cites·7 claims
- 1166US12447195B2Engineered SIRPα variants and methods of use thereofFBD BIOLOGICS LTD·Filed 2023·Granted Oct 21, 2025·0 cites·4 claims
- 1263US11970524B2Recombinant ROBO2 proteins, compositions, methods and uses thereofPFIZER·Filed 2020·Granted Apr 30, 2024·0 cites·25 claims
- 1360US2023250176A1Ppharmaceutical formulations and therapeutic uses of multi-specific binding proteins that bind egfr, nkg2d, and cd16DRAGONFLY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1459US10906955B2Recombinant ROBO2 proteins, compositions, methods and uses thereofPFIZER·Filed 2018·Granted Feb 2, 2021·0 cites·48 claims
- 1558US10196433B2Osteogenic proteinsWYETH LLC·Filed 2017·Granted Feb 5, 2019·0 cites·20 claims
- 1658US2023220106A1Antibodies targeting 5t4 and uses thereofDRAGONFLY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1755US2024360219A1Cd47/pd-l1-targeting protein complex and methods of use thereofFBD BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1855US2023203202A1Proteins binding nkg2d, cd16 and 5t4DRAGONFLY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1955US2023257467A1Proteins binding nkg2d, cd16 and egfrDRAGONFLY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2054US2023279121A1Antibodies targeting egfr and use thereofDRAGONFLY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2153US2024228584A1Engineered tgfbrii variants and methods of use thereofFBD BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 2252US2024117054A1Proteins binding nkg2d, cd16 and flt3DRAGONFLY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2352US2024228628A9Antibodies targeting flt3 and use thereofDRAGONFLY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2451US2025115658A1Engineered pd-1 variants and methods of use thereofFBD BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 2546US2025288643A1ENGINEERED SIRPá VARIANTS AND METHODS OF USE THEREOFFBD BIOLOGICS LTD·Filed 2025·Application pending·0 cites
- 2644US11365253B2Anti-ROBO2 antibodies, compositions, methods and uses thereofPFIZER·Filed 2018·Granted Jun 21, 2022·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Zong Sean Juo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →